Azithromycin and Glucosamine May Amplify the Type 1 Interferon Response to RNA Viruses in a Complementary Fashion
Overview
Affiliations
Previous research demonstrates that, in clinically relevant concentrations, azithromycin can boost the ability of RNA viruses to induce type 1 interferon by amplifying the expression and virally-mediated activation of MDA5. O-GlcNAcylation of MAVS, a down-stream target of MDA5, renders it more effective for type 1 interferon induction. High-dose glucosamine administration up-regulates O-GlcNAcylation by increasing the cellular pool of UDP-N-acetylglucosamine. Hence, it is proposed that joint administration of azithromycin and high-dose glucosamine, early in the course of RNA virus infections, may interact in a complementary fashion to aid their control by enhancing type 1 interferon induction.
A determination of pan-pathogen antimicrobials?.
Prathapan P Med Drug Discov. 2022; 14:100120.
PMID: 35098103 PMC: 8785259. DOI: 10.1016/j.medidd.2022.100120.
Baysal O, Abdul Ghafoor N, Silme R, Ignatov A, Kniazeva V PLoS One. 2021; 16(5):e0252571.
PMID: 34043733 PMC: 8158907. DOI: 10.1371/journal.pone.0252571.
Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections.
DiNicolantonio J, McCarty M, Barroso-Aranda J Open Heart. 2021; 8(1).
PMID: 33741691 PMC: 7985934. DOI: 10.1136/openhrt-2020-001568.